Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection-Reference-Cited by-同舟云学术

Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection

Published:2021-07 Issue: Volume:96 Page:107606
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Meng Guang-Qiang,Wang Jing-Shi,Wang Yi-Ni,Wei Na,Wang Zhao

Funder

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference22 articles.

1. Hemophagocytic lymphohistiocytosis;Skinner;AACN Adv. Crit. Care,2019

2. Hemophagocytic syndrome and critical illness: new insights into diagnosis and management;Tothova;J. Intensive Care Med.,2015

3. Epstein-Barr virus and hemophagocytic lymphohistiocytosis;Marsh;Front. Immunol.,2018

4. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation;Henter;Blood,2002

5. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults;La Rosée;Blood,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical utility of plasma Epstein-Barr virus DNA monitoring in pediatric Epstein‐Barr virus-associated hemophagocytic lymphohistiocytosis: a Chinese retrospective observational study;Italian Journal of Pediatrics;2024-07-30

2. Autoimmune encephalitis followed by hemophagocytic lymph histiocytosis: a case report;Frontiers in Immunology;2024-07-22

3. Hemophagocytic lymphohistiocytosis after solid organ transplantation: A challenge for clinicians;Transplant Immunology;2024-04

4. Cytokine Storm Syndromes Associated with Epstein–Barr Virus;Advances in Experimental Medicine and Biology;2024

5. Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report;IRAN J IMMUNOL;2023